These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9403492)

  • 1. Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome.
    Matsuishi T; Nagamitsu S; Yamashita Y; Murakami Y; Kimura A; Sakai T; Shoji H; Kato H; Percy AK
    Ann Neurol; 1997 Dec; 42(6):978-81. PubMed ID: 9403492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased cerebrospinal fluid levels of beta-phenylethylamine in patients with Rett syndrome.
    Satoi M; Matsuishi T; Yamada S; Yamashita Y; Ohtaki E; Mori K; Riikonen R; Kato H; Percy AK
    Ann Neurol; 2000 Jun; 47(6):801-3. PubMed ID: 10852546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid.
    Ormazabal A; Artuch R; Vilaseca MA; Aracil A; Pineda M
    Neuropediatrics; 2005 Dec; 36(6):380-5. PubMed ID: 16429378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low CSF HVA levels in the Rett syndrome: a reflection of restricted synapse formation?
    Nielsen JB; Bertelsen A; Lou HC
    Brain Dev; 1992 May; 14 Suppl():S63-5. PubMed ID: 1378245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome.
    Ramaekers VT; Sequeira JM; Artuch R; Blau N; Temudo T; Ormazabal A; Pineda M; Aracil A; Roelens F; Laccone F; Quadros EV
    Neuropediatrics; 2007 Aug; 38(4):179-83. PubMed ID: 18058624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated CSF glutamate in Rett syndrome.
    Hamberger A; Gillberg C; Palm A; Hagberg B
    Neuropediatrics; 1992 Aug; 23(4):212-3. PubMed ID: 1357572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental profile of serum nerve growth factor levels in Rett complex.
    Calamandrei G; Aloe L; Hajek J; Zappella M
    Ann Ist Super Sanita; 2001; 37(4):601-5. PubMed ID: 12046231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cerebrospinal fluid levels of beta-endorphin in Japanese patients with Joseph disease.
    Matsuishi T; Sakai T; Nagamitsu S; Komori H; Iwashita H; Kato H
    Ann Neurol; 1994 Sep; 36(3):441-3. PubMed ID: 8080253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental aspects of cerebrospinal fluid levels of beta-phenylethylamine and it's role in pediatric neurological disorders.
    Satoi M
    Kurume Med J; 1999; 46(1):17-23. PubMed ID: 10319609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rett syndrome. A report of fifteen cases].
    Echenne B; Bressot N; Cheminal R; Van Leuwen F; Compagnon P; Azaïs M
    Ann Pediatr (Paris); 1989 Dec; 36(10):661-8. PubMed ID: 2533856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evidence of brain stem immaturity in Rett syndrome.
    Julu PO; Kerr AM; Hansen S; Apartopoulos F; Jamal GA
    Eur Child Adolesc Psychiatry; 1997; 6 Suppl 1():47-54. PubMed ID: 9452920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rett syndrome: evidence for normal dopaminergic function.
    Wenk GL
    Neuropediatrics; 1996 Oct; 27(5):256-9. PubMed ID: 8971746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients.
    de Bont JM; Vanderstichele H; Reddingius RE; Pieters R; van Gool SW
    Eur J Paediatr Neurol; 2008 Jul; 12(4):334-41. PubMed ID: 17951083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiology and neurochemistry of Rett syndrome.
    Percy AK
    Eur Child Adolesc Psychiatry; 1997; 6 Suppl 1():80-2. PubMed ID: 9452927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine in Rett syndrome.
    Uldall P; Hansen FJ; Tonnby B
    Neuropediatrics; 1993 Dec; 24(6):339-40. PubMed ID: 8133981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injury.
    Uzan M; Erman H; Tanriverdi T; Sanus GZ; Kafadar A; Uzun H
    Acta Neurochir (Wien); 2006 Nov; 148(11):1157-64; discussion. PubMed ID: 16964558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic observations of the brain in Rett syndrome.
    Bauman ML; Kemper TL; Arin DM
    Neuropediatrics; 1995 Apr; 26(2):105-8. PubMed ID: 7566446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome).
    Vaeroy H; Helle R; Førre O; Kåss E; Terenius L
    J Rheumatol; 1988 Dec; 15(12):1804-6. PubMed ID: 2466120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated concentration of hyaluronan in the cerebrospinal fluid is a secondary marker of spinal disorders: hyaluronan in the cerebrospinal fluid in patients with spinal disorders.
    Sakayama K; Kidani T; Sugawara Y; Masuno H; Matsuda Y; Yamamoto H
    J Spinal Disord Tech; 2006 Jun; 19(4):262-5. PubMed ID: 16778660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P immunoreactivity in Rett syndrome.
    Deguchi K; Antalffy BA; Twohill LJ; Chakraborty S; Glaze DG; Armstrong DD
    Pediatr Neurol; 2000 Apr; 22(4):259-66. PubMed ID: 10788742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.